Korsana Biosciences, Inc. (KRSA)
NASDAQ: KRSA · Real-Time Price · USD
32.54
+1.51 (4.87%)
At close: Oct 21, 2026, 4:00 PM EDT
32.54
0.00 (0.00%)
After-hours: Oct 21, 2026, 4:10 PM EDT
Korsana Biosciences Market Cap
Korsana Biosciences has a market cap or net worth of $1.48 billion as of October 21, 2026. It is the 8,346th most valuable company in the world and the 2,013th biggest in the United States. Its market cap has increased by 20,928.20% in one year.
Market Cap
1.48B
Enterprise Value
1.35B
1-Year Change
20,928.20%
Global Rank
Country Rank
#2,013 United States
Category
ChartMarket Cap Chart
Since March 18, 2019, Korsana Biosciences's market cap has increased from $193.31M to $1.48B, an increase of 666.62%. That is a compound annual growth rate of 30.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 1.48B | 30,556.87% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 1.48B |
| First Tracks Biotherapeutics | 1.47B |
| Ocular Therapeutix | 1.46B |
| ORIC Pharmaceuticals | 1.43B |
| Rapport Therapeutics | 1.41B |
| Tyra Biosciences | 1.41B |
| Inhibrx Biosciences | 1.40B |
| Nanobiotix | 1.39B |